AK

Arvind Kumar

Active Director Director DIN 08559815
DIN 08559815 First appointment Sep 2019 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Arvind Kumar

Data last updated:

Arvind Kumar is a Director at Braus Pharma Private Limited (since 2019). The company operates in Food And Beverages. Braus Pharma Private Limited reported revenue of ₹7,225 (FY 2024).

DIN 08559815
Primary Designation Director
Industry Food And Beverages
First Appointment 11 Sep 2019
Oldest Company Age 7 yrs
Largest company Braus Pharma Private Limited · ₹7,225 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Braus Pharma Private Limited U24304PY2019PTC008458
Director11 Sep 20192019₹7,225 (FY 2024)Active

Board colleagues of Arvind Kumar

NameDINCompanyDesignation
Gyantosh Kumar08559816Braus Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Braus Pharma Private Limited
Premium access

Shareholding and investment profile for Arvind Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arvind Kumar

Arvind Kumar currently holds 1 directorship: Braus Pharma Private Limited (Director, since 11 Sep 2019, revenue ₹7,225 (FY 2024)).

Arvind Kumar was first appointed on 11 Sep 2019 as Director at Braus Pharma Private Limited.

The current boards of Arvind Kumar's companies include Gyantosh Kumar (Braus Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available